Current concepts in MRI of focal and diffuse malignancy of bone marrow

Seminars in Musculoskeletal Radiology

Volumn 17, Issue 2, 2013, Pages 137-144

  Howe, Benjaminmatthew ^a   Johnson, Geoffreyb ^a,b   Wenger, Dorise ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

bone marrow; bone neoplasm; MRI; PET CT; whole body MRI

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; DIAGNOSTIC AGENT;

BONE MARROW; BONE MARROW NEOPLASMS; DIAGNOSTIC USE; HUMAN; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; WHOLE BODY IMAGING; BONE MARROW CANCER; METHODOLOGY; REVIEW;

BONE MARROW; BONE MARROW NEOPLASMS; CONTRAST MEDIA; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; WHOLE BODY IMAGING;

EID: 84877809580     PISSN: 10897860     EISSN: 1098898X     Source Type: Journal    
DOI: 10.1055/s-0033-1343069     Document Type: Article

References (58)

1. Vogler J. B. III, Murphy W. A. Bone marrow imaging. Radiology: 1988; 168 3 679 693
2. Taccone A., Oddone M., Dell'Acqua A. D., Occhi M., Ciccone M. A. MRI "road-mapo" of normal age-related bone marrow. II. Thorax, pelvis and extremities. Pediatr Radiol: 1995; 25 8 596 606
3. Taccone A., Oddone M., Occhi M., Dell'Acqua A. D., Ciccone M. A. MRI "road-mapo" of normal age-related bone marrow. I. Cranial bone and spine. Pediatr Radiol: 1995; 25 8 588 595
4. McMenamin D. S., Stuckey S. L., Potgieter G. J. T1 hyperintense vertebral column melanoma metastases. AJNR Am J Neuroradiol: 2007; 28 9 1817 1818 (Pubitemid 47598166)
5. Premkumar A., Marincola F., Taubenberger J., Chow C., Venzon D., Schwartzentruber D. Metastatic melanoma: correlation of MRI characteristics and histopathology. J Magn Reson Imaging: 1996; 6 1 190 194 (Pubitemid 126702464)
6. Mirowitz S. A., Apicella P., Reinus W. R., Hammerman A. M. MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images. AJR Am J Roentgenol: 1994; 162 1 215 221 (Pubitemid 24043704)
7. Nakatsu M., Hatabu H., Itoh H., et al. Comparison of short inversion time inversion recovery (STIR) and fat-saturated (chemsat) techniques for background fat intensity suppression in cervical and thoracic MR imaging. J Magn Reson Imaging: 2000; 11 1 56 60 (Pubitemid 30022944)
8. Pui M. H., Goh P. S., Choo H. F., Fok E. C. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences. Australas Radiol: 1997; 41 2 99 102 (Pubitemid 27244098)
9. Berquist T. H. MRI of the Musculoskeletal System. 5th ed. Philadelphia, PA Lippincott Williams & Wilkins: 2006
10. Bloem J. L. Dynamic gadolinium-enhanced MR imaging in bone marrow disorders. Radiology: 2003; 227 1 303; author reply 304-305
11. Mosher T. J. Diagnostic effectiveness of gadolinium-enhanced MR imaging in evaluation of abnormal bone marrow signal. Radiology: 2002; 224 2 320 322 (Pubitemid 34809106)
12. Schmid M. R., Hodler J., Vienne P., Binkert C. A., Zanetti M. Bone marrow abnormalities of foot and ankle: STIR versus T1-weighted contrast-enhanced fat-suppressed spin-echo MR imaging. Radiology: 2002; 224 2 463 469 (Pubitemid 34809128)
13. Van der Woude H. J., Egmont-Petersen M. Contrast-enhanced magnetic resonance imaging of bone marrow. Semin Musculoskelet Radiol: 2001; 5 1 21 33 (Pubitemid 32238552)
14. Baur A., Stäbler A., Bartl R., Lamerz R., Scheidler J., Reiser M. MRI gadolinium enhancement of bone marrow: age-related changes in normals and in diffuse neoplastic infiltration. Skeletal Radiol: 1997; 26 7 414 418 (Pubitemid 27338910)
15. Bollow M., Knauf W., Korfel A., et al. Initial experience with dynamic MR imaging in evaluation of normal bone marrow versus malignant bone marrow infiltrations in humans. J Magn Reson Imaging: 1997; 7 1 241 250 (Pubitemid 28365668)
16. van Rijswijk C. SP, Geirnaerdt M. JA, Hogendoorn P. CW., et al. Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results. Eur Radiol: 2003; 13 8 1849 1858 (Pubitemid 36949711)
17. Cohen M. D. MRI and the detection of bone marrow tumor. AJR Am J Roentgenol: 2008; 190 1 W75
18. Northam M., de Campos R. OP, Ramalho M., et al. Bone metastases: evaluation of acuity of lesions using dynamic gadolinium-chelate enhancement, preliminary results. J Magn Reson Imaging: 2011; 34 1 120 127
19. Zha Y., Li M., Yang J. Dynamic contrast enhanced magnetic resonance imaging of diffuse spinal bone marrow infiltration in patients with hematological malignancies. Korean J Radiol: 2010; 11 2 187 194
20. Rahmouni A., Montazel J. L., Divine M., et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology: 2003; 229 3 710 717 (Pubitemid 37467573)
21. Katsuya T., Inoue T., Ishizaka H., Aoki J., Endo K. Dynamic contrast-enhanced MR imaging of the water fraction of normal bone marrow and diffuse bone marrow disease. Radiat Med: 2000; 18 5 291 297
22. Moulopoulos L. A., Maris T. G., Papanikolaou N., Panagi G., Vlahos L., Dimopoulos M. A. Detection of malignant bone marrow involvement with dynamic contrast-enhanced magnetic resonance imaging. Ann Oncol: 2003; 14 1 152 158 (Pubitemid 36150273)
23. Zhang L., Mandel C., Yang Z. Y., et al. Tumor infiltration of bone marrow in patients with hematological malignancies: dynamic contrast-enhanced magnetic resonance imaging. Chin Med J (Engl): 2006; 119 15 1256 1262
24. Chen B. B., Hsu C. Y., Yu C. W., et al. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission. Radiology: 2011; 258 3 821 831
25. Biffar A., Sourbron S., Schmidt G., et al. Measurement of perfusion and permeability from dynamic contrast-enhanced MRI in normal and pathological vertebral bone marrow. Magn Reson Med: 2010; 64 1 115 124
26. Griffith J. F., Yeung D. K., Antonio G. E., et al. Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology: 2006; 241 3 831 838 (Pubitemid 46190550)
27. Montazel J. L., Divine M., Lepage E., Kobeiter H., Breil S., Rahmouni A. Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging. Radiology: 2003; 229 3 703 709 (Pubitemid 37467572)
28. Wismer G. L., Rosen B. R., Buxton R., Stark D. D., Brady T. J. Chemical shift imaging of bone marrow: preliminary experience. AJR Am J Roentgenol: 1985; 145 5 1031 1037 (Pubitemid 16234120)
29. Disler D. G., McCauley T. R., Ratner L. M., Kesack C. D., Cooper J. A. In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water. AJR Am J Roentgenol: 1997; 169 5 1439 1447 (Pubitemid 27452518)
30. Erly W. K., Oh E. S., Outwater E. K. The utility of in-phase/opposed- phase imaging in differentiating malignancy from acute benign compression fractures of the spine. AJNR Am J Neuroradiol: 2006; 27 6 1183 1188 (Pubitemid 44897622)
31. Baunin C., Schmidt G., Baumstarck K., et al. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results. Skeletal Radiol: 2012; 41 9 1141 1149
32. Baur A., Stäbler A., Brüning R., et al. Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology: 1998; 207 2 349 356 (Pubitemid 28259047)
33. Balliu E., Vilanova J. C., Peláez I., et al. Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions. Eur J Radiol: 2009; 69 3 560 566
34. Baur A., Stäbler A., Arbogast S., Duerr H. R., Bartl R., Reiser M. Acute osteoporotic and neoplastic vertebral compression fractures: fluid sign at MR imaging. Radiology: 2002; 225 3 730 735 (Pubitemid 35387109)
35. Finelli D. A. Diffusion-weighted imaging of acute vertebral compressions: specific diagnosis of benign versus malignant pathologic fractures. AJNR Am J Neuroradiol: 2001; 22 2 241 242 (Pubitemid 32163449)
36. Yuh W. T., Zachar C. K., Barloon T. J., Sato Y., Sickels W. J., Hawes D. R. Vertebral compression fractures: distinction between benign and malignant causes with MR imaging. Radiology: 1989; 172 1 215 218 (Pubitemid 19192512)
37. Yeung D. K., Wong S. Y., Griffith J. F., Lau E. M. Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging: 2004; 19 2 222 228 (Pubitemid 38166800)
38. Li X., Kuo D., Schafer A. L., et al. Quantification of vertebral bone marrow fat content using 3. Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging: 2011; 33 4 974 979
39. Liu Y., Tang G. Y., Tang R. B., Peng Y. F., Li W. Assessment of bone marrow changes in postmenopausal women with varying bone densities: magnetic resonance spectroscopy and diffusion magnetic resonance imaging. Chin Med J (Engl): 2010; 123 12 1524 1527
40. Griffith J. F., Yeung D. K., Chow S. K., Leung J. C., Leung P. C. Reproducibility of MR perfusion and (1)H spectroscopy of bone marrow. J Magn Reson Imaging: 2009; 29 6 1438 1442
41. Zhang J., Cheng K., Ding Y., et al. Study of single voxel (1)H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors. Eur J Radiol: 2011; Dec 12
42. Hillner B. E., Liu D., Coleman R. E., et al. The National Oncologic PET Registry (NOPR): design and analysis plan. J Nucl Med: 2007; 48 11 1901 1908 (Pubitemid 350099337)
43. Squillaci E., Manenti G., Mancino S., et al. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT-initial clinical experience. Abdom Imaging: 2008; 33 6 676 688
44. Takenaka D., Ohno Y., Matsumoto K., et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging: 2009; 30 2 298 308
45. Antoch G., Vogt F. M., Freudenberg L. S., et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA: 2003; 290 24 3199 3206 (Pubitemid 38020681)
46. Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer: 1975; 36 3 842 854
47. Durie B. G. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer: 2006; 42 11 1539 1543 (Pubitemid 44137426)
48. Dimopoulos M., Terpos E., Comenzo R. L., et al. IMWG International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia: 2009; 23 9 1545 1556
49. Greipp P. R., San Miguel J., Durie B. G., et al. International staging system for multiple myeloma. J Clin Oncol: 2005; 23 15 3412 3420
50. Baur-Melnyk A., Buhmann S., Dürr H. R., Reiser M. Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol: 2005; 55 1 56 63 (Pubitemid 40798488)
51. Fonti R., Salvatore B., Quarantelli M., et al. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. J Nucl Med: 2008; 49 2 195 200 (Pubitemid 351225656)
52. Jadvar H., Conti P. S. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol: 2002; 31 12 690 694 (Pubitemid 36104567)
53. Shortt C. P., Gleeson T. G., Breen K. A., et al. Whole-Body MRI versus PET in assessment of multiple myeloma disease activity. AJR Am J Roentgenol: 2009; 192 4 980 986
54. Armitage J. O. Staging non-Hodgkin lymphoma. CA Cancer J Clin: 2005; 55 6 368 376 (Pubitemid 41677378)
55. Ribrag V., Vanel D., Leboulleux S., et al. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy. Eur J Radiol: 2008; 66 2 325 331 (Pubitemid 351626403)
56. Wu L. M., Chen F. Y., Jiang X. X., Gu H. Y., Yin Y., Xu J. R. 18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis. Eur J Radiol: 2012; 81 2 303 311
57. Yasumoto M., Nonomura Y., Yoshimura R., et al. MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging. Skeletal Radiol: 2002; 31 5 263 269 (Pubitemid 36075468)
58. van Ufford H. M., Kwee T. C., Beek F. J., et al. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. AJR Am J Roentgenol: 2011; 196 3 662 669